ASML Holding NV (AMSL.NL), the Dutch leader in semiconductor equipment, reported its Q4 2024 and full-year results on January 29, 2025. The company delivered better-than-expected performance, despite recent market turbulence sparked by concerns over AI-related demand shifts.
Key Highlights
Q4 2024 Performance
- Net Sales: €9.26 billion (above €9.07 billion consensus).
- Net Income: €2.69 billion (beat €2.64 billion forecast).
- Gross Margin: 51.7%, exceeding guidance and reflecting operational efficiency.
- Net Bookings: €7.1 billion, up 169% from Q3, with €3.0 billion from EUV systems.
Full-Year 2024 Results
- Total Net Sales: €28.3 billion, up from €27.6 billion in 2023.
- Net Income: €7.6 billion, reflecting strong profitability.
- Gross Margin: 51.3%.
- Lithography Systems Sold: 380 units (119 in Q4).
2025 Guidance
- Q1 2025 Net Sales: €7.5–8.0 billion, with gross margins at 52–53%.
- Full-Year 2025 Net Sales: €30–35 billion, supported by AI growth and robust order momentum.
Dividend Update
- ASML proposes a total dividend for 2024 of €6.40 per share, a 4.9% increase year-over-year.
- Interim dividend of €1.52 per share payable on February 19, 2025.
CEO Commentary
Christophe Fouquet, President and CEO of ASML, highlighted the company`s strong Q4 results, driven by robust demand for EUV and upgrades to High-NA EUV systems. He acknowledged challenges in customer dynamics caused by the rise of cost-efficient AI models, such as DeepSeek, but reaffirmed ASML`s commitment to innovation and adaptability.
“The growth in artificial intelligence remains a key driver for our industry, but it is creating both opportunities and risks for our customers, as reflected in our 2025 revenue range.”
Market Impact and Analyst Insights
- ASML`s net bookings surged to €7.1 billion in Q4, far surpassing analyst expectations of €3.99 billion.
- The company`s EUV bookings (€3.0 billion) highlight continued reliance on advanced chip-making technologies, despite concerns about evolving AI demand.
- Analysts praised ASML for its resilient performance amid shifting market dynamics.
Challenges:
- Concerns remain about long-term demand for EUV systems due to the potential disruption caused by Chinese AI models like DeepSeek.
- Geopolitical tensions and export restrictions could limit growth in the Chinese market.
Opportunities:
- ASML`s monopoly on EUV technology and its strong recurring revenue streams from Installed Base Management provide a stable foundation for growth.
Earnings Call Details:
- Date: January 29, 2025
- Time: 3:00 PM CET (9:00 AM ET)
For ASML the cash session has not yet started. However, the stock is gaining up to 8% in pre-market trading on some exchanges, suggesting an opening of spot trading even in the region of €700 per share.
Salesforce announces partnerships with OpenAI and Anthropic🚨
Intel down 5% 📉
JPMorgan, Goldman Sachs, and Citigroup: Sector Overview and Challenges
AMD Gains 3% on Oracle Processor Integration Announcement
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
